Skip to main content

Table 5 Hazard ratios (with 95% confidence intervals) for mortality according to hemofilter

From: Results of the 2018 Japan Society for Blood Purification in Critical Care survey: current status and outcomes

Hemofilters

n

Unadjusted

Adjusted for baseline characteristics

HR

95%CI

P value

HR

95%CI

P value

PS

675

1.00

Reference

–

1.00

Reference

–

PMMA

440

1.29

1.01–1.64

0.039

1.14

0.91–1.43

0.225

AN69ST

412

1.19

0.93–1.53

0.156

0.95

0.77–1.17

0.638

Others

337

0.58

0.43–0.77

0.001

0.85

0.63–1.12

0.265

  1. HRs for 28-day mortality in patients who were treated with continuous renal replacement therapy according to hemofilters, determined using standard Cox proportional-hazards regression analysis and adjusted for characteristics at baseline (age, sex, presence or absence of sepsis, acute kidney injury, acute lung injury, acute liver failure, cardiovascular hypotension, coagulation disorders, central nervous system disease, and APACHE II score). AN69ST acrylonitrile-co-methallyl sulfonate surface-treated, APACHE Acute Physiology and Chronic Health Evaluation, CI confidence interval, HR hazard ratio, PMMA polymethylmethacrylate, PS polysulfone